Cargando…

The role of N6-methyladenosine-modified non-coding RNAs in the pathological process of human cancer

Non-coding RNAs (ncRNAs) account for the majority of the widespread transcripts of mammalian genomes. They rarely encode proteins and peptides, but their regulatory role is crucial in numerous physiological and pathological processes. The m6A (N6-methyladenosine) modification is one of the most comm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Lin, Zhen, Yingwei, Peng, Dazhao, Wei, Cheng, Zhang, Xiaoyang, Liu, Xianzhi, Han, Lei, Zhang, Zhenyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293946/ https://www.ncbi.nlm.nih.gov/pubmed/35851061 http://dx.doi.org/10.1038/s41420-022-01113-2

Ejemplares similares

The emerging roles of N6-methyladenosine (m6A)-modified long non-coding RNAs in human cancers
por: Liu, Jingwen, et al.
Publicado: (2022)

Analysis of N6-methyladenosine-modified mRNAs in diabetic cataract
por: Cai, Lei, et al.
Publicado: (2023)

The functions of N6-methyladenosine modification in lncRNAs
por: He, Rong-Zhang, et al.
Publicado: (2020)

Novel insight into the functions of N6-methyladenosine modified lncRNAs in cancers (Review)
por: He, Yingjie, et al.
Publicado: (2022)

Positive natural selection of N6-methyladenosine on the RNAs of processed pseudogenes
por: Tan, Liqiang, et al.
Publicado: (2021)

The Role of N(6)-Methyladenosine Modified Circular RNA in Pathophysiological Processes
por: Tang, Mei, et al.
Publicado: (2021)

The Interaction Between N(6)-Methyladenosine Modification and Non-Coding RNAs in Gastrointestinal Tract Cancers
por: Yao, Lin, et al.
Publicado: (2022)

Interplay Between N(6)-Methyladenosine (m(6)A) and Non-coding RNAs in Cell Development and Cancer
por: Fazi, Francesco, et al.
Publicado: (2019)

Extensive translation of circular RNAs driven by N(6)-methyladenosine
por: Yang, Yun, et al.
Publicado: (2017)

Crosstalk among N6-methyladenosine modification and RNAs in central nervous system injuries
por: Tian, Mi, et al.
Publicado: (2022)

circRNA N6-methyladenosine methylation in preeclampsia and the potential role of N6-methyladenosine-modified circPAPPA2 in trophoblast invasion
por: Zhang, Yonggang, et al.
Publicado: (2021)

Comprehensive analysis of lncRNAs N(6)-methyladenosine modification in colorectal cancer
por: Zuo, Luo, et al.
Publicado: (2021)

New roles of N6-methyladenosine methylation system regulating the occurrence of non-alcoholic fatty liver disease with N6-methyladenosine-modified MYC
por: Cheng, Wenli, et al.
Publicado: (2022)

Identification and characterization of N6‐methyladenosine modification of circRNAs in glioblastoma
por: Zhang, Yuhao, et al.
Publicado: (2021)

Transcriptome-wide N6-methyladenosine modification profiling of long non-coding RNAs during replication of Marek’s disease virus in vitro
por: Sun, Aijun, et al.
Publicado: (2021)

Small-Molecule Ebselen Binds to YTHDF Proteins Interfering with the Recognition of N(6)-Methyladenosine-Modified RNAs
por: Micaelli, Mariachiara, et al.
Publicado: (2022)

N6-methyladenosine-related non-coding RNAs are potential prognostic and immunotherapeutic responsiveness biomarkers for bladder cancer
por: Lu, Miaolong, et al.
Publicado: (2021)

The Relationship Between the Network of Non-coding RNAs-Molecular Targets and N6-Methyladenosine Modification in Colorectal Cancer
por: Lu, Senxu, et al.
Publicado: (2021)

The role of N(6)-methyladenosine (m(6)A) modification in the regulation of circRNAs
por: Zhang, Lele, et al.
Publicado: (2020)

Research Progress on Long Noncoding RNAs and N6-Methyladenosine in Hepatocellular Carcinoma
por: Zhang, Wenjie, et al.
Publicado: (2022)

N6-Methyladenosine-Related lncRNAs Are Anticipated Biomarkers for Sarcoma Patients
por: Zhang, Xiaohe, et al.
Publicado: (2022)

N6-methyladenosine Modification of Noncoding RNAs: Mechanisms and Clinical Applications in Cancer
por: Ma, Mingyang, et al.
Publicado: (2022)

YTHDC1 mediates nuclear export of N(6)-methyladenosine methylated mRNAs
por: Roundtree, Ian A, et al.
Publicado: (2017)

N(6)-methyladenosine is required for the hypoxic stabilization of specific mRNAs
por: Fry, Nate J., et al.
Publicado: (2017)

Identification of N6-Methyladenosine-Associated Long Non-coding RNAs for Immunotherapeutic Response and Prognosis in Patients With Pancreatic Cancer
por: Yu, Xinshuang, et al.
Publicado: (2021)

N6-Methyladenosine Related Long Non-Coding RNAs and Immune Cell Infiltration in the Tumor Microenvironment of Gastric Cancer
por: Yu, Zhong lin, et al.
Publicado: (2021)

Comprehensive analysis of N6-methyladenosine -related long non-coding RNAs and immune cell infiltration in hepatocellular carcinoma
por: Yu, Zhong Lin, et al.
Publicado: (2021)

Comprehensive analysis of N(6)‐methyladenosine‐related long non‐coding RNAs for prognosis prediction in liver hepatocellular carcinoma
por: Zhu, Hong‐Xu, et al.
Publicado: (2021)

N6-methyladenosine Modification-Related Long Non-Coding RNAs are Potential Biomarkers for Predicting the Prognosis of Patients With Osteosarcoma
por: Yang, Kun, et al.
Publicado: (2022)

Identification of genes modified by N6-methyladenosine in patients with colorectal cancer recurrence
por: Zhu, Qianru, et al.
Publicado: (2022)

Distribution Patterns of DNA N6-Methyladenosine Modification in Non-coding RNA Genes
por: Li, Yu, et al.
Publicado: (2020)

Analysis and verification of N(6)-methyladenosine-modified genes as novel biomarkers for clear cell renal cell carcinoma
por: Yang, Zhenyu, et al.
Publicado: (2021)

N6-methyladenosine modulates long non-coding RNA in the developing mouse heart
por: Shen, Siman, et al.
Publicado: (2022)

Identification of N6-Methyladenosine-Related lncRNAs as a Prognostic Signature in Glioma
por: Chen, Yujia, et al.
Publicado: (2022)

Comprehensive analysis of the PD-L1 and immune infiltrates of N6-methyladenosine related long non-coding RNAs in bladder cancer
por: Xue, M. Q., et al.
Publicado: (2022)

Relationships of N6-Methyladenosine-Related Long Non-Coding RNAs With Tumor Immune Microenvironment and Clinical Prognosis in Lung Adenocarcinoma
por: Zhao, Jianhui, et al.
Publicado: (2021)

Non-coding RNA and n6-methyladenosine modification play crucial roles in neuropathic pain
por: Zhang, Kexin, et al.
Publicado: (2022)

The Roles of N(6)-Methyladenosine in Human Diseases
por: An, Shanshan, et al.
Publicado: (2019)

Integrated Analysis of the Immune Infiltrates and PD-L1 Expression of N6-Methyladenosine-Related Long Non-Coding RNAs in Colorectal Cancer
por: Jiang, Ziting, et al.
Publicado: (2021)

The dual role of N6‐methyladenosine modification of RNAs is involved in human cancers
por: He, Liujia, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1omomrcf2o969radrolvuknnqa